Compare AdaptHealth Corp (AHCO) vs Valero Energy Corporation (VLO) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AdaptHealth Corp vs Valero Energy Corporation — how do they compare? AdaptHealth Corp trades at $10.04 (market cap $1.38B), while Valero Energy Corporation trades at $283.08 (market cap $79.05B). The key difference: Valero Energy Corporation is far larger — about 57.3× AdaptHealth Corp's market cap, and Valero Energy Corporation pays a 1.8% dividend while AdaptHealth Corp pays none. Which is the better fit depends on your goals.
| AHCO | VLO | |
|---|---|---|
Market Cap | $1.38B | $79.05B |
Sector | Health | Energy |
52-Week High | $13.38 | $270.32 |
52-Week Low | $8.68 | $131.77 |
Enterprise Value | $3.33B | $84.81B |
Dividend Yield | — | 1.8% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.
The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.
Valero Energy (VLO) trades at $266.22, down 0.58% on the day, with strong technical momentum showing bullish moving averages and key resistance at $270. The company has consistently beaten earnings estimates in recent quarters, with Q2 2026 expected at $10.08 EPS. Fundamentals show solid profitability with 17.72% ROE and attractive valuation metrics including P/E of 19.75 and P/S of 0.66. Recent news highlights VLO's refining strength and renewable fuels growth potential.
VLO presents a compelling investment case with strong analyst support (58% buy ratings) and a consensus price target of $258.25. The company's Gulf Coast refining advantage and clean-fuel initiatives support long-term growth, though investors face risks from energy market volatility and declining revenue trends from $176.4B in 2022 to $122.7B in 2025. The current price near resistance levels suggests potential for breakout or consolidation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AdaptHealth Corp
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →About Valero Energy Corporation
Valero Energy is one of the largest independent refiners in the United States. It operates 14 refineries with a total throughput capacity of 3.2 million barrels a day in the United States, Canada, and the United Kingdom. Valero also owns 14 ethanol plants with capacity of 1.7 billion gallons of ethanol a year and holds a 50% stake in Diamond Green Diesel, which has capacity to produce 700 million gallons per year of renewable diesel.
Read more on VLO →
